Shanghai OPM Biosciences Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	21.05	54.04	105.37	60.39
Depreciation & Amortization	45.68	36.83	33.85	28.19
Other Amortization	12.39	5.88	5.17	4.07
Loss (Gain) From Sale of Assets	-0.09	-	-0.29	-
Asset Writedown & Restructuring Costs	7.51	0.02	0	0.02
Loss (Gain) From Sale of Investments	-18.25	-14.59	-5.81	-4.18
Provision & Write-off of Bad Debts	6.92	6.42	4.76	0.31
Other Operating Activities	-0.6	1.99	3.01	5.11
Change in Accounts Receivable	-39.23	-24.83	-46.04	-6.3
Change in Inventory	-9.41	-5.62	-10.56	-21.26
Change in Accounts Payable	38.54	-8.16	16.82	40.52
Change in Other Net Operating Assets	5.5	6.87	5.79	7.87
Operating Cash Flow	69.25	57.95	111.62	114.63
Operating Cash Flow Growth	19.49%	-48.08%	-2.62%	3478.75%
Capital Expenditures	-120.86	-77.55	-146.96	-105.98
Sale of Property, Plant & Equipment	-	-	6.78	-
Cash Acquisitions	-	0.02	-	-
Investment in Securities	-253.73	-73.26	-283.28	-38
Other Investing Activities	4.05	1.25	37.87	3.99
Investing Cash Flow	-370.54	-149.53	-385.59	-139.99
Long-Term Debt Issued	-	-	32.34	42.82
Long-Term Debt Repaid	-11.3	-45.42	-62.79	-21.6
Net Debt Issued (Repaid)	-11.3	-45.42	-30.45	21.22
Issuance of Common Stock	-	-	1,523	-
Repurchase of Common Stock	-37.25	-13.75	-	-
Common Dividends Paid	-51.22	-73.83	-2.08	-1.8
Other Financing Activities	0.13	-	-15.74	0.2
Financing Cash Flow	-99.64	-133.01	1,474	19.62
Foreign Exchange Rate Adjustments	2.42	0.95	2.35	-0.24
Net Cash Flow	-398.51	-223.64	1,203	-5.99
Free Cash Flow	-51.61	-19.59	-35.34	8.64
Free Cash Flow Margin	-17.36%	-8.06%	-12.01%	4.06%
Free Cash Flow Per Share	-0.44	-0.17	-0.35	0.10
Cash Income Tax Paid	29.9	11.38	28.47	13.42
Levered Free Cash Flow	-48.83	-38.18	-100.94	-34.34
Unlevered Free Cash Flow	-46.88	-36.16	-97.83	-31.35
Change in Working Capital	-5.37	-32.64	-34.44	20.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.